Leerink Raises Price Target on MedAssets (MDAS) Following 2Q EPS Beat
Tweet Send to a Friend
Leerink Partners reiterated a Market Perform rating on MedAssets (NASDAQ: MDAS), and raised the price target to $22.00 (from $21.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
